Results 131 to 140 of about 53,957 (281)

Bridging the Gap Between General and Transplant Infectious Disease Practice

Transplant Infectious Disease, EarlyView.
ABSTRACT The population of iatrogenic immunocompromised individuals is steadily rising as we continue to improve in our ability to manage diseases, including cancer, autoimmune disease, and end‐organ dysfunction, with increasing access to novel agents and transplantation.
Jeremey Walker, Emily Eichenberger, Steven Pergam, Maricar Malinis, Andrea J. Zimmer   +4 more
wiley   +1 more source

Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.

, 2011
Current management of autosomal dominant polycystic kidney disease (ADPKD) is focused on treating disease complications, not on slowing cyst development or preventing progression to kidney failure.
Grantham, Jared J., Vicente E. Torres, Torres, Vicente E., Meijer, Esther, Eiji Higashihara, Kyongtae T. Bae, Olivier Devuyst, Ronald D. Perrone, Chapman, Arlene B., Krasa, Holly B., Higashihara, Eiji, John J. Ouyang, Perrone, Ronald D., Esther Meijer, Ouyang, John J., Bae, Kyongtae T., Jared J. Grantham, Arlene B. Chapman, Devuyst, Olivier, Ron T. Gansevoort, Gansevoort, Ron T., Czerwiec, Frank S., Holly B. Krasa, Frank S. Czerwiec   +23 more
core   +1 more source

A Quarter Century of EHD Protein Research: From Endosomal Recycling to Ciliopathies

Traffic, Volume 27, Issue 3, September 2026.
Human EHD protein subcellular localization. ABSTRACT Eps15 homology domain‐containing proteins comprise a conserved family of membrane‐remodeling ATPases that regulate endocytic trafficking, membrane fission, receptor recycling, primary ciliogenesis and membrane dynamics across eukaryotes. Since the initial identification of EHD1 and its Caenorhabditis
Devin Frisby, Gunjan Misri, Naava Naslavsky, Steve Caplan   +3 more
wiley   +1 more source

A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease

, 2015
Autosomal dominant polycystic kidney disease (ADPKD) is marked by gradual renal cyst and kidney enlargement and ultimately renal failure. Magnetic resonance-based, height-adjusted total kidney volume (htTKV) over 600 cc/m predicts the development of CKD ...
Grantham, Jared J., Mrug, Michal, Torres, Vicente E., Ge, Yinghui, Bhutani, Harpreet, Chapman, Arlene B., Wu, Zhiyuan, Smith, Vikram, Mittal, Ankush, Landslittel, Doug, Gibbs, Patrice, Bae, Kyongtae T., O'Neill, W. Charles, Rahbari-Oskoui, Frederic   +13 more
core   +1 more source

In Vitro Fertilization is Essential Healthcare for Patients With Rheumatic Disease

ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Infertility presents a profound physical, emotional, and financial burden, particularly for rheumatology patients who often face substantial barriers to family building. The 2024 Alabama Supreme Court ruling in LePage v. Center for Reproductive Medicine equating embryo destruction with wrongful death introduced new legal uncertainties, sparking ...
Amanda Moyer, Catherine A. Sims, Rosalind Ramsey‐Goldman, Solmaz Chamanara, Cuoghi Edens   +4 more
wiley   +1 more source

Giant thrombus entrapped by a patent foramen ovale in a patient with polycystic kidney disease

Clinical and Biomedical Research, 2017
Polycystic kidney disease (PKD) is the most common genetic cause of chronic kidney disease (CKD). The most common cause of death in patients with this condition is cardiovascular disease, mainly due to hypertension and its consequences.
Gustavo Neves de Araujo, Stéfani Mariani, Felipe Pereira Lima Marques, Lucas Simonetto Faganello, Luís Henrique Klafke, Douglas Dal Más Freitas, Solano Berger   +6 more
doaj   +2 more sources

Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease11Thomas Andreoli, M.D., served as Guest Editor for this paper.

, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.βBackgroundAutosomal-dominant polycystic kidney disease (ADPKD) is an inherited disorder characterized by renal cyst ...
Grantham, Jared J., Guay-Woodford, Lisa M., Torres, Vicente E., Bennett, William M., King, Bernard F., Chapman, Arlene B., Felmlee, Joel P., Brummer, Marijn E., Kimmel, Paul L., Miller, J. Phillip, Glockner, James F., Hirschman, Gladys H., Thompson, Paul A., the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP),, Bae, Kyongtae T., Klahr, Saulo, Arya, Kraisthith   +16 more
core   +1 more source

Cardiovascular–kidney–metabolic syndrome stage modifies the efficacy of intensive blood pressure control on cognitive outcomes: A post hoc analysis of SPRINT MIND

Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION Whether cardiovascular–kidney–metabolic (CKM) syndrome stage modifies cognitive benefits of intensive blood pressure (BP) control remains unclear. METHODS This post hoc analysis of ‌Systolic Blood Pressure Intervention Trial – Memory and Cognition in Decreased Hypertension (SPRINT MIND) classified participants into non‐advanced ...
Zhongxiao Wang, Junyu Pei, Tienan Sun, Siqi Ge, Taoyang Wu, Yuzhe Yin, Haipeng Wang, Jialiang Yang, Keyang Zheng   +8 more
wiley   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 168-177, July 2026.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source

Polycystic kidney and Down Syndrome

Journal of Research in Medical Sciences, 2006
Kidney disease is not a common complication in Down Syndrome (DS). A variety of renal and urologic problems have been described in these patients and some develop renal failure. Coincidence of polycystic kidney disease and DS is a rare entity.
Azar Nickavar
doaj